DocMorris AGXSWX:DOCM +1.65%65 12-1 Month Momentum % is 11.32% as of Jul. 05, 2026. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.56 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 663 Healthcare Providers & Services companies, DocMorris AG ranks better than 73.15% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-07-05), DocMorris AG's 12-1 Month Momentum % is 11.32%.
The industry rank for DocMorris AG's 12-1 Month Momentum % or its related term are showing as below:
XSWX:DOCM's 12-1 Month Momentum % is ranked better than 73.15% of 663
companies
in the Healthcare Providers & Services industry
Industry Median: -10
vs XSWX:DOCM: 11.32
DocMorris AG (XSWX:DOCM) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
DocMorris AG 12-1 Month Momentum % Related Terms
DocMorris AG 12-1 Month Momentum % Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG 12-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where DocMorris AG's 12-1 Month Momentum % falls into.
DocMorris AG (XSWX:DOCM) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) has a 12-1 Month Momentum % of 11.32% as of Jul. 05, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on DocMorris AG and its competitors. According to the industry distribution chart, DocMorris AG ranks #178 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 26.8%.
Is DocMorris AG's 12-1 Month Momentum % too high?
DocMorris AG's current 12-1 Month Momentum % is 11.32%. Based on the distribution chart, DocMorris AG ranks #178 out of 663 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's 12-1 Month Momentum % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #178 out of 663 companies for 12-1 Month Momentum %. This puts DocMorris AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Providers & Services company?
A good 12-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on DocMorris AG and its competitors. DocMorris AG's current 12-1 Month Momentum % is 11.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.56, compared to a current price of CHF9.25 — trading 12.4% below its estimated fair value. The current 12-1 Month Momentum % is 11.32%. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current 12-1 Month Momentum % is 11.32% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF9.25 is trading 12.4% below its estimated GF Value™ of CHF10.56.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
12-1 Month Momentum %: 11.32%
GF Value™: CHF10.56 vs. price of CHF9.25 (12.4% below fair value)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 